Loading...

ADC Therapeutics SA (NYSE:ADCT)

7.89 USD +1.01 USD ( +14.68% )
Watchlist Manager
ADC Therapeutics SA
NYSE:ADCT
Watchlist

DCF Value

Estimated DCF Value of one ADCT stock under the base case scenario is 1.27 USD. Compared to the current market price of 7.89 USD, the stock is Overvalued by 84%.

Estimated DCF Value of one NYSE:ADCT stock is 1.27 USD. Compared to the current market price of 7.89 USD, the stock is Overvalued by 84% .

DCF valuation is one of two methods of placing a monetary value on a company; the other is Relative Valuation method. We use a combination of these two methods to calculate the Intrinsic Value of stock as accurately as possible.

Discount Rate
7.36%
Terminal Growth
0%
Growth Period
5 Years
Discount Rate
7.36%
Terminal Growth
0%
Growth Period
5 Years

You can change any inputs, such as future revenue, using Present Value Calculation block.

ADCT DCF Value
Base Case
1.27 USD
Overvaluation 84%
DCF Value
Price
A
Worst Case
Base Case
Best Case
Open DCF Settings
Close DCF Settings
ADC Therapeutics SA Competitors:
DCF Valuation
CCXI
ChemoCentryx Inc
8247
Biosino Bio-Technology and Science Inc
AREC
Arecor Therapeutics PLC
FYB
Formycon AG
FRLN
Freeline Therapeutics Holdings PLC
VNDA
Vanda Pharmaceuticals Inc
PHMMF
Pharma Mar SA
RGLS
Regulus Therapeutics Inc

DCF Value Calculation

Capital Structure
From Present Value to DCF Value

Present Value -97.7M USD
+ Cash & Equivalents 467M USD
+ Investments 41.2M USD
Firm Value 410M USD
- Debt 313M USD
Equity Value 97.3M USD
/ Shares Outstanding 76.8M
ADCT DCF Value 1.27 USD
Overvalued by 84%

To view the process of calculating the Present Value of ADC Therapeutics SA' future free cash flow, see the Present Value Calculation block.

Present Value Calculation

Discounted Cash Flow Model
Present Value of Free Cash Flow

Rotate your device for better experience.

To view the process of deriving the DCF Value of one share from the estimated Present Value, see the DCF Value Calculation block.

DCF Model Financials
Financials used in the DCF Model

Sensitivity Analysis

Sensitivity Analysis
DCF Value Sensitivity Analysis

Analyze the possible values of ADCT stock DCF Value given various model inputs such as Revenue Growth, Operating Margin, and Discount Rate.

See Also

Similar Stocks

ADCT Stock DCF Valuation FAQ

What is the DCF value of one ADCT stock?

Estimated DCF Value of one ADCT stock under the base case scenario is 1.27 USD. Compared to the current market price of 7.89 USD, the stock is Overvalued by 84%.

The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock intrinsic values gives a complete picture of the investment risks and opportunities.

How was the DCF Value calculated?

1. Present Value Calculation. Using the DCF Operating Model we project ADC Therapeutics SA's future free cash flow and discount it at a selected discount rate to calculate its Present Value (-97.7M USD).

2. DCF Value Calculation. We use the company's capital structure to calculate the total Equity Value based on the previously computed Present Value of the free cash flow. Dividing the Equity Value by the number of shares outstanding gives us the DCF Value of 1.27 USD per one ADCT share.